Abstract
Patients with syndromic craniosynostosis have a molecularly identified genetic cause for the premature closure of their cranial sutures and associated facial and extra-cranial features. Their clinical complexity demands comprehensive management by an extensive multidisciplinary team. This review aims to marry genotypic and phenotypic knowledge with clinical presentation and management of the craniofacial syndromes presenting most frequently to the craniofacial unit at Great Ormond Street Hospital for Children NHS Foundation Trust.
References
1.
Abu-Sittah GS, Jeelani O, Dunaway D, Hayward R: Raised intracranial pressure in Crouzon syndrome: incidence, causes, and management. J Neurosurg Pediatr 17:469-475 (2016).
2.
Agochukwu NB, Solomon BD, Muenke M: Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses. Childs Nerv Syst 28:1447-1463 (2012a).
3.
Agochukwu NB, Solomon BD, Gropman AL, Muenke M: Epilepsy in Muenke syndrome: FGFR3-related craniosynostosis. Pediatr Neurol 47:355-361 (2012b).
4.
Ahmad F, Cobb AR, Mills C, Jones BM, Hayward RD, Dunaway DJ: Frontofacial monobloc distraction in the very young: a review of 12 consecutive cases. Plast Reconstr Surg 129:488e-497e (2012).
5.
Anderson PJ, Hall C, Evans RD, Harkness WJ, Hayward RD, Jones BM: The cervical spine in Crouzon syndrome. Spine (Phila Pa 1976) 22:402-405 (1997a).
6.
Anderson PJ, Hall CM, Evans RD, Jones BM, Hayward RD: The feet in Crouzon syndrome. J Craniofac Genet Dev Biol 17:43-47 (1997b).
7.
Britto JA, Chan JC, Evans RD, Hayward RD, Jones BM: Differential expression of fibroblast growth factor receptors in human digital development suggests common pathogenesis in complex acrosyndactyly and craniosynostosis. Plast Reconstr Surg 107:1331-1338 (2001).
8.
Buchanan EP, Xue AS, Hollier LH Jr: Craniofacial syndromes. Plast Reconstr Surg 134:128e-153e (2014).
9.
Cartwright CC, Jimenez DF, Barone CM, Baker L: Endoscopic strip craniectomy: a minimally invasive treatment for early correction of craniosynostosis. J Neurosci Nurs 35:130-138 (2003).
10.
Chaudhry A, Sabatini P, Han L, Ray PN, Forrest C, Bowdin S: Heterozygous mutations in ERF cause syndromic craniosynostosis with multiple suture involvement. Am J Med Genet A 167A:2544-2547 (2015).
11.
Cho E, Yang TH, Shin ES, Byeon JH, Kim GH, Eun BL: Saethre-Chotzen syndrome with an atypical phenotype: identification of TWIST microdeletion by array CGH. Childs Nerv Syst 29:2101-2104 (2013).
12.
Chotzen F: Eine eigenartige familiäre Entwicklungsstörung (Akrocephalosyndaktylie, Dystosis craniofacialis und Hypertelorismus). Monatsschr Z Kinderheilkd 55:97-122 (1932).
13.
Cohen MM Jr: Craniofrontonasal dysplasia. Birth Defects Orig Artic Ser 15:85-89 (1979).
14.
Cohen MM Jr: Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis. Am J Med Genet 45:300-307 (1993).
15.
Cohen MM Jr, Kreiborg S: Cutaneous manifestations of Apert syndrome. Am J Med Genet 58:94-96 (1995).
16.
Collmann H, Sörensen N, Krauss J: Hydrocephalus in craniosynostosis: a review. Childs Nerv Syst 21:902-912 (2005).
17.
Connolly JP, Gruss J, Seto ML, Whelan MF, Ellenbogen R, et al: Progressive postnatal craniosynostosis and increased intracranial pressure. Plast Reconstr Surg 113:1313-1323 (2004).
18.
Copeland AE, Hoffman CE, Tsitouras V, Jeevan DS, Ho ES, et al: Clinical significance of venous anomalies in syndromic craniosynostosis. Plast Reconstr Surg Glob Open 6:e1613 (2018).
19.
Crombag GA, Verdoorn MH, Nikkhah D, Ponniah AJ, Ruff C, Dunaway D: Assessing the corrective effects of facial bipartition distraction in Apert syndrome using geometric morphometrics. J Plast Reconstr Aesthet Surg 67:e151-161 (2014).
20.
de Jong T, Bannink N, Bredero-Boelhouwer HH, van Veelen ML, Bartels MC, et al: Long-term functional outcome in 167 patients with syndromic craniosynostosis; defining a syndrome-specific risk profile. J Plast Reconstr Aesthet Surg 63:1635-1641 (2010).
21.
de Jong T, van Veelen ML, Mathijssen IM: Spring-assisted posterior vault expansion in multisuture craniosynostosis. Childs Nerv Syst 29:815-820 (2013).
22.
Derderian CA, Wink JD, McGrath JL, Collinsworth A, Bartlett SP, Taylor JA: Volumetric changes in cranial vault expansion: comparison of fronto-orbital advancement and posterior cranial vault distraction osteogenesis. Plast Reconstr Surg 135:1665-1672 (2015).
23.
Di Rocco F, Collet C, Legeai-Mallet L, Arnaud E, Le Merrer M. et al: Crouzon syndrome with acanthosis nigricans: a case-based update. Childs Nerv Syst 27:349-354 (2011).
24.
Di Rocco F, Baujat G, Arnaud E, Rénier D, Laplanche JL, et al: Clinical spectrum and outcomes in families with coronal synostosis and TCF12 mutations. Eur J Hum Genet 22:1413-1416 (2014).
25.
Doherty ES, Lacbawan F, Hadley DW, Brewer C, Zalewski C, et al: Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am J Med Genet A 143A:3204-3215 (2007).
26.
Florisson JM, Barmpalios G, Lequin M, van Veelen ML, Bannink N, et al: Venous hypertension in syndromic and complex craniosynostosis: the abnormal anatomy of the jugular foramen and collaterals. J Craniomaxillofac Surg 43:312-318 (2015).
27.
Forrest CR, Hopper RA: Craniofacial syndromes and surgery. Plast Reconstr Surg 131:86e-109e (2013).
28.
Gault DT, Renier D, Marchac D, Jones BM: 1992. Intracranial pressure and intracranial volume in children with craniosynostosis. Plast Reconstr Surg 90:377-381 (1992).
29.
Glaser RL, Jiang W, Boyadjiev SA, Tran AK, Zachary AA, et al: Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet 66:768-777 (2000).
30.
Goldstein JA, Paliga JT, Wink JD, Low DW, Bartlett SP, Taylor JA: A craniometric analysis of posterior cranial vault distraction osteogenesis. Plast Reconstr Surg 131:1367-1375 (2013).
31.
Goos JA, Fenwick AL, Swagemakers SM, McGowan SJ, Knight SJ, et al: Identification of intragenic exon deletions and duplication of TCF12 by whole genome or targeted sequencing as a cause of TCF12-related craniosynostosis. Human Mutat 37:732-736 (2016).
32.
Greig AV, Wagner J, Warren SM, Grayson B, McCarthy JG: Pfeiffer syndrome: analysis of a clinical series and development of a classification system. J Craniofac Surg 24:204-215 (2013).
33.
Grosso S, Farnetani MA, Berardi R, Bartalini G, Carpentieri M, et al: Medial temporal lobe dysgenesis in Muenke syndrome and hypochondroplasia. Am J Med Genet A 120A:88-91 (2003).
34.
Hanieh A, David DJ: Apert's syndrome. Childs Nerv Syst 9:289-291 (1993).
35.
Hayward R: Venous hypertension and craniosynostosis. Childs Nerv Syst 21:880-888 (2005).
36.
Hayward R, Jones B, Dunaway D, Evans R (eds): Clinical Management of Craniosynostosis (Mac Keith Press, London 2004).
37.
Hopper RA, Kapadia H, Morton T: Normalizing facial ratios in Apert syndrome patients with Le Fort II midface distraction and simultaneous zygomatic repositioning. Plast Reconstr Surg 132:129-140 (2013).
38.
Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, et al: Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15:36-41 (1997).
39.
Jarrahy R, Kawamoto HK, Keagle J, Dickinson BP, Katchikian HV, Bradley JP: Three tenets for staged correction of Kleeblattschädel or cloverleaf skull deformity. Plast Reconstr Surg 123:310-318 (2009).
40.
Johnson D, Wilkie AO: Craniosynostosis. Eur J Hum Genet 19:369-376 (2011).
41.
Johnson D, Horsley SW, Moloney DM, Oldridge M, Twigg SR, et al: A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet 63:1282-1293 (1998).
42.
Kawamoto HK, Heller JB, Heller MM, Urrego A, Gabbay JS, et al: Craniofrontonasal dysplasia: a surgical treatment algorithm. Plast Reconstr Surg 120:1943-1956 (2007).
43.
Khonsari RH, Way B, Nysjö J, Odri GA, Olszewski R, et al: Fronto-facial advancement and bipartition in Crouzon-Pfeiffer and Apert syndromes: impact of fronto-facial surgery upon orbital and airway parameters in FGFR2 syndromes. J Craniomaxillofac Surg 44:1567-1575 (2016).
44.
Kolar JC, Munro IR, Farkas LG: Patterns of dysmorphology in Crouzon syndrome: an anthropometric study. Cleft Palate J 25:235-244 (1988).
45.
Kreiborg S: Crouzon syndrome. A clinical and roentgencephalometric study. Scand J Plast Reconstr Surg Suppl 18:1-198 (1981).
46.
Kreiborg S, Barr M, Cohen MM Jr: Cervical spine in the Apert syndrome. Am J Med Genet A 43:704-708 (1992).
47.
Kruszka P, Addissie YA, Yarnell CM, Hadley DW, Guillen Sacoto MJ, et al: Muenke syndrome: an international multicenter natural history study. Am J Med Genet A 170A:918-929 (2016).
48.
Kung TA, Vercler CJ, Muraszko KM, Buchman SR: Endoscopic strip craniectomy for craniosynostosis: do we really understand the indications, outcomes, and risks? J Craniofac Surg 27:293-298 (2016).
49.
Lajeunie E, Cameron R, El Ghouzzi V, de Parseval N, Journeau P, et al: Clinical variability in patients with Apert's syndrome. J Neurosurg 90:443-447 (1999).
50.
Marucci DD, Dunaway DJ, Jones BM, Hayward RD: Raised intracranial pressure in Apert syndrome. Plast Reconstr Surg 122:1162-1168 (2008).
51.
Moss ML: Functional anatomy of cranial synostosis. Childs Brain 1:22-33 (1975).
52.
Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, et al: A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60:555-564 (1997).
53.
Nowinski D, Di Rocco F, Renier D, SainteRose C, Leikola J, Arnaud E: Posterior cranial vault expansion in the treatment of craniosynostosis. Comparison of current techniques. Childs Nerv Syst 28:1537-1544 (2012).
54.
Patton MA, Goodship J, Hayward R, Lansdown R: Intellectual development in Apert's syndrome: a long term follow up of 29 patients. J Med Genet 25:164-167 (1988).
55.
Peterson SJ, Pruzansky S: Palatal anomalies in the syndromes of Apert and Crouzon. Cleft Palate J 11:394-403 (1974).
56.
Pfeiffer RA: Dominant hereditary acrocephalosyndactylia (in German). Z Kinderheilkd 90:301-320 (1964).
57.
Pickrell BB, Meaike JD, Cañadas KT, Chandy BM, Buchanan EP: Tracheal cartilaginous sleeve in syndromic craniosynostosis: an underrecognized source of significant morbidity and mortality. J Craniofac Surg 28:696-699 (2017).
58.
Raposo-Amaral CE, Neto JG, Denadai R, Raposo-Amaral CM, Raposo-Amaral CA: Patient- reported quality of life in highest-functioning Apert and Crouzon Syndromes. Plast Reconstr Surg 133:182e-191e (2014).
59.
Reddy K, Hoffman H, Armstrong D: Delayed and progressive multiple suture craniosynostosis. Neurosurgery 26:442-448 (1990).
60.
Renier D, Lajeunie E, Arnaud E, Marchac D: Management of craniosynostoses. Childs Nerv Sys16:645-658 (2000).
61.
Rice DP: Clinical features of syndromic craniosynostosis. Front Oral Biol 12:91-106 (2008).
62.
Robin NH, Falk MJ, Haldeman-Englert CR: FGFR-related craniosynostosis syndromes, in Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al (eds): GeneReviews® [Internet] (University of Washington, Seattle (WA): Seattle 1993-2018). Initial posting: Oct 20, 1998; last update: June 7, 2011.
63.
Saethre H: Ein Beitrag zum Turmschädelproblem (Pathogenese, Erblichkeit und Symptomologie). Dtsch Z Nervenheilkd 117:533-555 (1931).
64.
Schweitzer DN, Graham JM Jr, Lachman RS, Jabs EW, Okajima K, et al: Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3. Am J Med Genet A 98:75-91 (2001).
65.
Sharma VP, Fenwick AL, Brockop MS, McGowan SJ, Goos JA, et al: Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet 45:304-307 (2013).
66.
Spruijt B, Rijken BF, den Ottelander BK, Joosten KF, Lequin MH, et al: First vault expansion in Apert and Crouzon-Pfeiffer syndromes: front or back? Plast Reconstr Surg 137:112e-121e (2016).
67.
Tay T, Martin F, Rowe N, Johnson K, Poole M, et al: Prevalence and causes of visual impairment in craniosynostotic syndromes. Clin Exp Ophthalmol 34:434-440 (2006).
68.
Taylor JA, Bartlett SP: 2017. What's new in syndromic craniosynostosis surgery? Plast Reconstr Surg140:82e-93e (2017).
69.
Taylor JA, Derderian CA, Bartlett SP, Fiadjoe JE, Sussman EM, Stricker PA: Perioperative morbidity in posterior cranial vault expansion: distraction osteogenesis versus conventional osteotomy. Plast Reconstr Surg 129:674e-680e (2012).
70.
Taylor WJ, Hayward RD, Lasjaunias P, Britto JA, Thompson DN, et al: Enigma of raised intracranial pressure in patients with complex craniosynostosis: the role of abnormal intracranial venous drainage. J Neurosurg 94:377-385 (2001).
71.
Thompson DN, Hayward RD, Harkness WJ, Bingham RM, Jones BM: Lessons from a case of Kleeblattschädel. Case report. J Neurosurg 82:1071-1074 (1995).
72.
Thompson DN, Slaney SF, Hall CM, Shaw D, Jones BM, Hayward RD: Congenital cervical spinal fusion: a study in Apert syndrome. Pediatr Neurosurg 25:20-27 (1996).
73.
Tovetjärn R, Tarnow P, Maltese G, Fischer S, Sahlin PE, Kölby L: Children with Apert syndrome as adults: a follow-up study of 28 Scandinavian patients. Plast Reconstr Surg 130:572e-576e (2012).
74.
Twigg SR, Wilkie AO: A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet 97:359-377 (2015).
75.
Twigg SR, Vorgia E, McGowan SJ, Peraki I, Fenwick AL, et al: Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet 45:308-313 (2013).
76.
van den Elzen ME, Twigg SR, Goos JA, Hoogeboom AJ, van den Ouweland AM, et al: Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1. Eur J Hum Genet 22:995-1001 (2014).
77.
Wang JC, Nagy L, Demke JC: Syndromic craniosynostosis. Facial Plast Surg Clin North Am 24:531-543 (2016).
78.
Wilkie AOM, Johnson D, Wall SA: Clinical genetics of craniosynostosis. Curr Opin Pediatr 29:622-628 (2017).
79.
Witherow H, Dunaway D, Ponniah A, Hayward R: Monobloc distraction in an infant, using the rigid external distractor: problems and solutions-a case report. J Craniomaxillofac Surg 36:15-20 (2008).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
